Any capital venture investor who wants to see a decent return in three to four years, says John Moragne, co-founder and managing director of investment firm Trident Capital. Even as deals dry up, Moragne sees huge potential in medicine, alternative energy and even information technology — especially in light of today’s depressed valuations.